Boston Technology Review: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Boston Technology Review.

Press releases published on May 4, 2026

May 4, 2026

Eton Pharmaceuticals to Report First Quarter 2026 Financial Results on Thursday, May 14, 2026

Indeterminate GlobeNewswire

May 4, 2026

BioAge to Host R&D Day Focused on NLRP3 Inhibition on May 8, 2026

Indeterminate GlobeNewswire

May 4, 2026

CVRx Announces First Patient Enrollment in BENEFIT-HF, a Landmark Heart Failure Trial Evaluating Barostim in Significantly Expanded Population

Indeterminate GlobeNewswire

May 4, 2026

Anaptys to Participate at the H.C. Wainwright 2nd Annual Royalty Company Virtual Conference

Indeterminate GlobeNewswire

May 4, 2026

Kuvi Integrates with KuCoin Broker Pro to Advance Agentic Finance Adoption

Indeterminate GlobeNewswire

May 4, 2026

3 E Network Technology Signs 1.3M Convertible Note Agreement with Institutional Investor

Indeterminate GlobeNewswire

May 4, 2026

Kyntra Bio to Report First Quarter 2026 Financial Results

Indeterminate GlobeNewswire

May 4, 2026

Tactile Systems Technology, Inc. Reports First Quarter 2026 Financial Results

Indeterminate GlobeNewswire

May 4, 2026

Rumble Announces Timing of First Quarter 2026 Earnings Release and Conference Call

Indeterminate GlobeNewswire

May 4, 2026

Clip Money Inc. Announces Amendment of Unsecured Convertible Notes

Indeterminate GlobeNewswire

May 4, 2026

EverQuote Announces First Quarter 2026 Financial Results

Indeterminate GlobeNewswire

May 4, 2026

Silvaco Announces Participation at Upcoming Investor Conferences

Indeterminate GlobeNewswire

May 4, 2026

Capricor Therapeutics to Report First Quarter 2026 Financial Results and Provide Recent Corporate Update on May 12

Indeterminate GlobeNewswire

May 4, 2026

Lexicon Pharmaceuticals Announces $100 Million Loan Facility with Hercules Capital

Indeterminate GlobeNewswire

May 4, 2026

Aktis Oncology Initiates Phase 1b Clinical Trial for AKY-2519, a B7-H3 Miniprotein Radioconjugate, in Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Indeterminate GlobeNewswire

May 4, 2026

ORIC® Pharmaceuticals Reports First Quarter 2026 Financial Results and Operational Updates

Indeterminate GlobeNewswire

May 4, 2026

Ocugen Announces Private Offering of $115 Million of Convertible Senior Notes

Indeterminate GlobeNewswire

May 4, 2026

Praxis Precision Medicines to Report First Quarter 2026 Financial Results on Thursday, May 7, 2026, and Participate in Upcoming Investor Conference

Indeterminate GlobeNewswire

May 4, 2026

FibroBiologics Reports Preclinical Data Showing Fibroblast Spheroids May Actively Reprogram the Burn Wound Environment to Drive Healing and Reduce Scarring

Indeterminate GlobeNewswire

May 4, 2026

Biodesix Announces First Quarter 2026 Results and Highlights

Indeterminate GlobeNewswire